NN
Narumi Nakagiri Daiwa Capital Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Illumina
ILMN
$15.7B
| $98.93 | $154 |
56%
upside
| Buy | 1 year ago |
|
2 |
2
Pfizer
PFE
$141B
| $24.88 | $34 |
37%
upside
| Outperform | 1 year ago |
|
3 |
3
Johnson & Johnson
JNJ
$430B
| $178.43 | $150 |
16%
downside
| Neutral | 1 year ago |
|
4 |
4
Amgen
AMGN
$153B
| $283.64 | $320 |
13%
upside
| Buy | 1 year ago |
|
5 |
5
Bristol-Myers Squibb
BMY
$96B
| $47.14 | $54 |
15%
upside
| Neutral | 1 year ago |
|
6 |
6
Merck
MRK
$212B
| $84.71 | $102 |
20%
upside
| Outperform | 3 years ago |
|